Respiratory Diseases Unit, Medical Department, AOU Maggiore della Carità, Novara, Italy -
Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy -
Panminerva Med. 2021 Dec;63(4):529-538. doi: 10.23736/S0031-0808.21.04533-X. Epub 2021 Oct 4.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has changed bronchoscopy practices worldwide. Bronchoscopy is a high-risk aerosol-generating procedure with a potential for direct SARS-CoV-2 exposure and hospital-acquired infection. Current guidelines about personal protective equipment and environment considerations represent key competencies to minimize droplets dispersion and reduce the risk of transmission. Different measures should be put in field based on setting, patient's clinical characteristics, urgency and indications of bronchoscopy. The use of this technique in SARS-CoV-2 patients is reported primarily for removal of airway plugs and for obtaining microbiological culture samples. In mechanically ventilated patients with SARS-CoV-2, bronchoscopy is commonly used to manage complications such as hemoptysis, atelectasis or lung collapse when prone positioning, physiotherapy or recruitment maneuvers have failed. Further indications are represented by assistance during percutaneous tracheostomy. Continuous positive airway pressure, non-invasive ventilation support and high flow nasal cannula oxygen are frequently used in patient affected by Coronavirus disease 2019 (COVID-19): management of patients' airways and ventilation strategies differs from bronchoscopy indications, patient's clinical status and in course or required ventilatory support. Sedation is usually administered by the pulmonologist (performing the bronchoscopy) or by the anesthetist depending on the complexity of the procedure and the level of sedation required. Lastly, elective bronchoscopy for diagnostic indications during COVID-19 pandemic should be carried on respecting rigid standards which allow to minimize potential viral transmission, independently from patient's COVID-19 status. This narrative review aims to evaluate the indications, procedural measures and ventilatory strategies of bronchoscopy performed in different settings during COVID-19 pandemic.
严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 大流行改变了全球的支气管镜检查实践。支气管镜检查是一种高风险的气溶胶产生程序,具有直接暴露于 SARS-CoV-2 和医院获得性感染的潜在风险。目前关于个人防护设备和环境注意事项的指南是将飞沫分散最小化并降低传播风险的关键能力。应根据设置、患者的临床特征、支气管镜检查的紧急程度和适应症,在现场采取不同的措施。该技术在 SARS-CoV-2 患者中的应用主要是为了清除气道堵塞物和获取微生物培养样本。在 SARS-CoV-2 机械通气患者中,支气管镜检查常用于管理并发症,如咯血、肺不张或肺塌陷,当俯卧位、物理治疗或复张手法失败时。进一步的适应症是在经皮气管切开术期间提供帮助。持续气道正压通气、无创通气支持和高流量鼻导管吸氧常用于 2019 年冠状病毒病 (COVID-19) 患者:患者气道和通气策略的管理不同于支气管镜检查的适应症、患者的临床状况以及在疾病过程中或需要的通气支持。镇静通常由行支气管镜检查的肺病学家(或麻醉师)根据手术的复杂性和所需镇静水平来管理。最后,在 COVID-19 大流行期间,出于诊断目的而进行的选择性支气管镜检查应在严格的标准下进行,以最大限度地减少潜在的病毒传播,而与患者的 COVID-19 状态无关。本叙述性综述旨在评估 COVID-19 大流行期间在不同环境下进行支气管镜检查的适应症、程序措施和通气策略。